MRI-based radiomic feature analysis of end-stage liver disease for severity stratification - Takeaways - MDSpire

MRI-based radiomic feature analysis of end-stage liver disease for severity stratification

  • By

  • Jennifer Nitsch

  • Jordan Sack

  • Michael W. Halle

  • Jan H. Moltz

  • April Wall

  • Anna E. Rutherford

  • Ron Kikinis

  • Hans Meine

  • March 1, 2021

  • 0 min

Share

  • 1

    Cirrhosis, caused by various chronic liver diseases, leads to significant mortality, with nearly two million deaths annually worldwide.

  • 2

    The MELD scoring system stratifies liver transplant candidates by estimating 90-day mortality based on serum creatinine, bilirubin, and INR.

  • 3

    MRI-based radiomic feature analysis can noninvasively assess liver disease severity and predict decompensation in cirrhotic patients.

  • 4

    This study uniquely focuses on MRI data from a single center to ensure consistency in feature extraction for cirrhosis severity assessment.

  • 5

    The goal is to develop a radiomic signature that enhances patient assessment and treatment guidance, potentially improving MELD transplant prioritization.

Original Source(s)

Related Content